In the News

1855 News Items found
Gus Frank is seen smiling with his older sister. Gus was treated for Ewing Sarcoma at MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center
Learn how a family with a young son diagnosed with Ewing sarcoma were helped by the experts at MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center.
Alexis Lopez, regional manager of material management and supply chain at MSK locations in New York State and New Jersey, with family
Alexis Lopez is a self-described “MSK baby,” due to the 23-year career he’s built at Memorial Sloan Kettering Cancer Center (MSK), as well as the three...
Medical oncologist and male breast cancer expert Ayca Gucalp
Feature
MSK experts discuss risk factors, symptoms, and treatment for male breast cancer.
Jorge Lopez, Jr.
Lopez was recognized for his positive impact on New York City through his professional, communal, and philanthropic achievements.
Craig Melvin
NBC News anchor Craig Melvin led MSK experts in a discussion about racial and age trends in colorectal cancer and when people should start screening for the disease.
A doctor showing a textured and smooth implant to their patient
Learn what you need to know about safety requirements for breast implants.
A healthcare provider comforts a patient by resting their hands on a patient's arm.
Feature
Nearly 400 adults and children have received umbilical cord blood transplants at MSK. These transplants offer the best chance of a cure for blood cancer in patients who are unable to find a matched donor, often due to their non-European ancestry.
genitourinary medical oncologist Robert Motzer
Q&A
Immunotherapy drugs called checkpoint inhibitors are effective against many cancers, including kidney cancer. Learn how these drugs are used to treat both early- and late-stage disease.
Mini Kamboj, MSK's Chief Medical Epidemiologist
Polio in NY: What You Should Know
Learn what detection of the polio virus in New York State means for you.
MSK medical oncologist Jonathan Rosenberg, who treats bladder cancer.
Antibody-drug conjugates and checkpoint inhibitors show promise as new therapies for bladder cancer.